BDUK Therapeutics
General Data
Reg Number
517065819
Sector
Biomed
Established
2024
No. of Employees
2
Stage
R&D
Additional Funding
1
Description
BDUK-Tx developed a breakthrough liver cancer therapy, combining existing drugs into a novel therapeutic product in a $11Bn liver cancer market with no real therapy and low survival rate, working to reach an M&A or license deal after Phase-1 readout
Technology
Drug-device product (delivery enabling platform).
Targeted Customers
Liver cancer market.
Management personnel
Walter Wasser - CEO & Co-Founder
Winning details
Route name
Winning year
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2025
Startup Fund
Startup Fund
2026